Stefano Rodinò

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

Antonio Tursi, Giovanni Brandimarte, Alfredo Papa et al. · The American Journal of Gastroenterology · 2010 · 491 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease - a double-blind, randomised, placebo-controlled study

Antonio Tursi, Giovanni Brandimarte, Walter Elisei et al. · Alimentary Pharmacology & Therapeutics · 2013 · 155 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy

Roberta Roberti, Luigi Francesco Iannone, Caterina Palleria et al. · Current Medical Research and Opinion · 2020 · 51 citations

Medicine, Internal Medicine, Pharmacology +11

Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients

Antonio Tursi, Giammarco Mocci, Roberto Lorenzetti et al. · European Journal of Gastroenterology & Hepatology · 2021 · 49 citations

Pharmacy, Immunology, Pharmacotherapy +14

Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey

Elisabetta Buscarini, A. Benedetti, Fabio Monica et al. · Digestive and Liver Disease · 2021 · 37 citations · Full text

Medicine, Infectious Diseases, Oncology +16